-8.15%
Today
Loading 1D prices…
Company profile
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Sector
Health Care
Industry
In Vitro & In Vivo Diagnostic Substances
Exchange
NYSE
Display currency
USD
Location
Henderson, NV, United States
Employees
57
Fiscal year end
1231
CIK
93314
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CDIOCardio Diagnostics Holdings Inc. Common stock | $6M | $14.8K | -43832.49% | -$3.71 | +2.53% | Hold |
| TRIBTrinity Biotech plc American Depositary Shares | $6.3M | $43.8M | -85.36% | -$53.10 | -0.64% | Unrated |
| BMRABiomerica Inc. Common Stock | $10.3M | $4.5M | -84.77% | -$1.30 | +0.45% | Unrated |
| QCLSQ/C Technologies Inc. Common Stock | $14M | $0.00 | — | -$8.66 | +4.24% | Unrated |
| VRAXVirax Biolabs Group Limited Ordinary Shares | $2.1M | $12.4K | -40439.10% | -$12.64 | -0.35% | Buy |